What We Do?
News & updates
1. Are you accepting new patients?
At this time, ABcann is growing its first batch of cannabis to be ready for testing in late Spring 2015. Product availability and registration dates are still yet to be determined.
2. How do I register with ABcann?
Registration includes completion of two different forms, the Registration Application and the Medical Document. The Medical Document, form B must be completed by a licensed physician, or a nurse practitioner. The Registration Application and Medical Document must be submitted together and sent to ABcann by mail. The mailing address is indicated on both forms.
1. How do the regulations affect me?
The goal of the MMPR as stated by Health Canada is to treat medical marihuana more like other pharmaceutical medications. Under the MMPR Health Canada will no longer serve as the authorization body for medical marijuana in Canada. Health Canada will not provide personal production or designated grower licenses, nor will Health Canada sell medical marijuana from a contracted supplier. Instead, Health Canada will license producers to provide dried marijuana directly to medical marijuana patients. Patients must first register with the Licensed Producer by submitting documentation including a Medical Document authorized by a licensed physician and the appropriate application form.
2. Is Medical Cannabis safe?
Medical cannabis is safer to use than prescription opiates (oxycontin and vicodin) according to a 2013 study published in The Lancet. The safety of cannabis is increased when prescribed by a person’s health care practitioner and purchased through a licensed producer.
1. What strains do you have?
ABcann is in the process of creating High CBD, blended THC/CBD and High THC strains.
2. How much does your product cost?
Currently our pricing is under development. When product is available we will have more information on pricing.
1. I am a Military Veteran. Is there any coverage for me?
Contact Veteran Affairs for additional information.
2. Does ABcann have a compassionate pricing program?
ABcann is in the process of developing a compassionate pricing program to provide accessibility for low income patients.
3. Will my medical plan cover the cost of medical cannabis?
We are lobbying with the insurance industry, as well as the Provincial financial support agencies to obtain financial assistance to cover the costs associated with our patient’s medical marijuana needs. We recommend that you discuss this directly with your insurance provider.
We are pleased to announce that Professor Raphael Mechoulam has joined the ABcann’s Research & Advisory Board. Professor Raphael Mechoulam (otherwise known as the Father of Marijuana Research) is an Israeli Organic Chemist and professor from the Department for Medicinal Chemistry and Natural Products at Hebrew University of Jerusalem Institute for Drug Research, Medical Faculty; is now in partnership with ABcann to on various research initiatives with regard to medical cannabis.
Why Become a Client
We are currently not accepting registrations.
For more information as to when registration will be available, please submit your information and a Client Care Representative will be in touch with you.
Looking Back and Ahead
Presented by: Professor Raphael Mechoulam
Hosted by: ABcann Medicinals and Queens University – School of Medicine
Controlled Growth Environment